4//SEC Filing
HIPP RAYMOND R 4
Accession 0001077183-19-000013
CIK 0001077183other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:57 PM ET
Size
16.5 KB
Accession
0001077183-19-000013
Insider Transaction Report
Form 4
HIPP RAYMOND R
Director
Transactions
- Sale
Common Stock
2019-02-26$18.90/sh−18,889$357,002→ 287,580 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-02-26−5,556→ 2,777 totalExercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (5,556 underlying) - Exercise/Conversion
Common Stock
2019-02-26$4.78/sh+10,000$47,800→ 297,580 total - Exercise/Conversion
Common Stock
2019-02-26$7.27/sh+3,333$24,231→ 306,469 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-02-26−10,000→ 0 totalExercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-02-26−3,333→ 6,667 totalExercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (3,333 underlying) - Exercise/Conversion
Common Stock
2019-02-26$9.11/sh+5,556$50,615→ 303,136 total
Holdings
- 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying)
Footnotes (3)
- [F1]On May 6, 2015, Mr. Hipp was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001188214
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:57 PM ET
- Size
- 16.5 KB